Carcinoid syndrome pathophysiology: Difference between revisions
| Line 7: | Line 7: | ||
==Pathogenesis== | ==Pathogenesis== | ||
The pathogenesis of the cardiac lesions and the [[bronchoconstriction]] is unknown. When the primary tumor is in the [[gastrointestinal tract]], as it is in the great majority of cases, the [[serotonin]] and [[kallikrein]] are inactivated in the [[liver]] and manifestations of carcinoid syndrome do not occur until there are metastases to the liver. The [[flushing]] results from secretion of [[kallikrein]], the [[enzyme]] that catalyzes the conversion of [[kininogen]] to lysyl-[[bradykinin]]. The latter is further converted to [[bradykinin]], one of the most powerful [[vasodilators]] known. Large amounts of [[tryptophan]] from synthesis of the [[vitamin]], [[niacin]], to the synthesis of 5-hydroxyindoles including serotonin produces [[pellagra]] like features including [[diarrhea]]. Carcinoid tumors arising in the [[bronchi]], reach the systemic circulation before passing through the [[liver]], may be associated with [[bronchoconstriction]] and manifestations of carcinoid syndrome without liver metastases. They have a very slow growth rate compared to most malignant tumors. Carcinoid heart disease develops in more than one-third of patients with carcinoid syndrome. Pathologically, the cardiac valves become thickened because of fibrosis, and the [[tricuspid]] and pulmonic valves are affected to a greater extent than the mitral and aortic valves. | The pathogenesis of the cardiac lesions and the [[bronchoconstriction]] is unknown. When the primary tumor is in the [[gastrointestinal tract]], as it is in the great majority of cases, the [[serotonin]] and [[kallikrein]] are inactivated in the [[liver]] and manifestations of carcinoid syndrome do not occur until there are metastases to the liver. The [[flushing]] results from secretion of [[kallikrein]], the [[enzyme]] that catalyzes the conversion of [[kininogen]] to lysyl-[[bradykinin]]. The latter is further converted to [[bradykinin]], one of the most powerful [[vasodilators]] known. Large amounts of [[tryptophan]] from synthesis of the [[vitamin]], [[niacin]], to the synthesis of 5-hydroxyindoles including serotonin produces [[pellagra]] like features including [[diarrhea]]. Carcinoid tumors arising in the [[bronchi]], reach the systemic circulation before passing through the [[liver]], may be associated with [[bronchoconstriction]] and manifestations of carcinoid syndrome without liver metastases. They have a very slow growth rate compared to most malignant tumors. Carcinoid heart disease develops in more than one-third of patients with carcinoid syndrome. Pathologically, the cardiac valves become thickened because of fibrosis, and the [[tricuspid]] and pulmonic valves are affected to a greater extent than the [[mitral]] and [[aortic valves]]. | ||
==Embryology== | ==Embryology== | ||
Revision as of 13:07, 25 September 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome pathophysiology |
|
Risk calculators and risk factors for Carcinoid syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Carcinoid syndrome refers to the array of symptoms that occur secondary to carcinoid tumors. Carcinoid tumors are discrete, yellow, well-circumscribed tumors that can occur anywhere along the gastrointestinal tract (GI). They most commonly affect the appendix, ileum, and rectum. These tumors are unique in that they are endocrine in nature. They secrete hormones into the blood stream, which then travel to end organs and act upon them via appropriate receptors.
Pathogenesis
The pathogenesis of the cardiac lesions and the bronchoconstriction is unknown. When the primary tumor is in the gastrointestinal tract, as it is in the great majority of cases, the serotonin and kallikrein are inactivated in the liver and manifestations of carcinoid syndrome do not occur until there are metastases to the liver. The flushing results from secretion of kallikrein, the enzyme that catalyzes the conversion of kininogen to lysyl-bradykinin. The latter is further converted to bradykinin, one of the most powerful vasodilators known. Large amounts of tryptophan from synthesis of the vitamin, niacin, to the synthesis of 5-hydroxyindoles including serotonin produces pellagra like features including diarrhea. Carcinoid tumors arising in the bronchi, reach the systemic circulation before passing through the liver, may be associated with bronchoconstriction and manifestations of carcinoid syndrome without liver metastases. They have a very slow growth rate compared to most malignant tumors. Carcinoid heart disease develops in more than one-third of patients with carcinoid syndrome. Pathologically, the cardiac valves become thickened because of fibrosis, and the tricuspid and pulmonic valves are affected to a greater extent than the mitral and aortic valves.
Embryology
Carcinoid tumours originate from neuroendocrine cells (Enterochromaffin or amine precursor uptake and decarboxylase [APUD] cells), which embryologically are of neural crest origin. Gastrointestinal carcinoids derive from cells that migrate from the neural crest to the foregut, midgut and hindgut.
Location
Carcinoid tumors are normally found throughout the gastrointestinal tract from mouth to anus, with the highest concentration of cells in the appendix and small intestine. The pancreas contains a large number of these cells, the biliary tree only a few and the liver normally contains none. Fibrotic lesions are found on endocardium, particularly on the right side of the heart.
Associated Conditions
Goblet Cell Carcinoid is considered to be a hybrid between an exocrine and endocrine tumor derived from crypt cells of the appendix. They behave in a more aggressive manner than do classical appendiceal carcinoids. Spread is usually to regional lymph nodes, peritoneum, and particularly the ovary. They do not produce sufficient hormonal substances to cause the carcinoid or other endocrine syndromes. In fact, they more closely resemble exocrine than endocrine tumors. The term 'crypt cell carcinoma' has been used for them, and though perhaps more accurate than considering them carcinoids, has not been a successful competitor.
Gross Pathology
Gastrointestinal Carcinoid
In the gastric or intestinal wall, carcinoids may occur as firm white, yellow, or gray nodules and may be intramural masses or may protrude into the lumen as polypoid nodules; the overlying gastric or intestinal mucosa may be intact or have focal ulceration. Primary carcinoids of the ovary are invariably unilateral. They form a solid nodule within a cystic teratoma, or form a pure solid hypervascular mass. They can be indistinguishable from other solid neoplasms of the ovary 5.
Ovarian Carcinoid
Lesions can markedly vary in size. Metastatic carcinoids are nearly always bilateral with scattered tumor deposits present throughout both ovaries. Primary carcinoids of the ovary are invariably unilateral. They form a solid nodule within a cystic teratoma, or form a pure solid hypervascular mass. They can be indistinguishable from other solid neoplasms of the ovary. Lesions can markedly vary in size. Metastatic carcinoids are nearly always bilateral with scattered tumor deposits present throughout both ovaries.[1]
Microscopic Pathology
Goblet Cell Carcinoid
Histologically, globet cell carcinoid forms clusters of goblet cells containing mucin with a minor admixture of paneth cells and endocrine cells. The growth pattern is distinctive: typically producing a concentric band of tumour nests interspersed among the muscle and stroma of the appendiceal wall extending up the shaft of the appendix. This makes the lesion difficult to suspect grossly and difficult to measure. Small tumor nests may be camouflaged amongst the muscle or in periappendiceal fat; cytokeratin preparations best demonstrate the tumor cells; mucin stains are also helpful in identifying them.
Gastric or Intestinal Carcinoid
Neuroendocrine cells have uniform nuclei and abundant granular or faintly staining (clear) cytoplasm, and are present as solid or small trabecular clusters, or are dispersed among other cells, which may make them difficult to recognize in sections stained with hematoxylin and eosin; immunostaining enables their exact identification. At the ultrastructural level, neuroendocrine cells contain cytoplasmic membrane-bound dense-cored secretory granules (diameter >80 nm) and may also contain small clear vesicles (diameter 40–80 nm) that correspond to the synaptic vesicles of neurons.[2]
Hepatic Carcinoid
Histologically, the tumor has features of classic carcinoid (i.e. trabecular and pseudoglandular pattern) and dense core granules demonstrated by electron microscopy or by immunohistochemistry (i.e. positive staining by chromogranin antibody).[3]
Video
{{#ev:youtube|hTSHJBAD3C4}}
Genetics
- Gastrointestinal carcinoids occur in association with inherited syndromes, such as MEN1 and NF1.[2]
- MEN1 is caused by alterations of the MEN1 gene located at chromosomal region 11q13. Most carcinoids associated with MEN1 appear to be of foregut origin.
- NF1 is an autosomal dominant genetic disorder caused by alteration of the NF1 gene at chromosome 17q11. Carcinoids in patients with NF1 appear to arise primarily in the periampullary region.
- In sporadic GI carcinoids, numerous chromosomal imbalances have been found by comparative genome hybridization analysis. Gains involving chromosomes 5, 14, 17 (especially 17q), and 19 and losses involving chromosomes 11 (especially 11q) and 18 appear to be the most common.
- The most frequently reported mutated gene in GI carcinoids is β-catenin (CTNNB1).
References
- ↑ Ovarian carcinoid tumours . Radiopaedia (date). http://radiopaedia.org/articles/ovarian-carcinoid-tumours Accessed on September 24, 2015
- ↑ 2.0 2.1 General Information About Gastrointestinal (GI) Carcinoid Tumors . National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq#link/_49_toc Accessed on September 24, 2015
- ↑ Hepatic carcinoid . Radiopaedia. http://radiopaedia.org/articles/bronchial-carcinoid-tumour Accessed on September 24, 2015